11/11
08:00 am
amix
Autonomix Medical, Inc. Reports Second Quarter Fiscal Year 2025 Financial Results and Provides a Corporate Update
Medium
Report
Autonomix Medical, Inc. Reports Second Quarter Fiscal Year 2025 Financial Results and Provides a Corporate Update
10/31
08:00 am
amix
Autonomix Medical, Inc. Reports New Positive Topline Results from First 15 Patients’ 7-Day Data Highlighting Significant Impact on Treatment of Pancreatic Cancer Pain with Maintained Pain Reduction
High
Report
Autonomix Medical, Inc. Reports New Positive Topline Results from First 15 Patients’ 7-Day Data Highlighting Significant Impact on Treatment of Pancreatic Cancer Pain with Maintained Pain Reduction
10/30
08:30 am
amix
Autonomix Medical, Inc.’s Dr. Robert Schwartz Discusses What Positive 4-6 Week Follow-Up Data Means from Lead-In Patients in Ongoing Human Clinical Trial
Medium
Report
Autonomix Medical, Inc.’s Dr. Robert Schwartz Discusses What Positive 4-6 Week Follow-Up Data Means from Lead-In Patients in Ongoing Human Clinical Trial
10/28
08:00 am
amix
Positive Preliminary Results Demonstrate Autonomix’s Proprietary RF Ablation Technology’s Ability to Reduce Opioid Use in Ongoing Human Clinical Trial
High
Report
Positive Preliminary Results Demonstrate Autonomix’s Proprietary RF Ablation Technology’s Ability to Reduce Opioid Use in Ongoing Human Clinical Trial
10/22
08:30 am
amix
Autonomix Announces Reverse Stock Split
Medium
Report
Autonomix Announces Reverse Stock Split
10/8
08:30 am
amix
Autonomix Medical, Inc. to Participate in the 2024 Healthcare Virtual Summit, Presented by Maxim Group LLC
Low
Report
Autonomix Medical, Inc. to Participate in the 2024 Healthcare Virtual Summit, Presented by Maxim Group LLC
10/3
10:09 am
amix
This Company Is Taking An Innovative, Non-Opioid Approach To Pain Management For Pancreatic Cancer [Yahoo! Finance]
Low
Report
This Company Is Taking An Innovative, Non-Opioid Approach To Pain Management For Pancreatic Cancer [Yahoo! Finance]
9/26
07:30 am
amix
Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment
Low
Report
Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment
9/20
08:48 am
amix
Autonomix Selected to Present at the 2024 Octane Medical Innovation Forum [Yahoo! Finance]
Low
Report
Autonomix Selected to Present at the 2024 Octane Medical Innovation Forum [Yahoo! Finance]
9/20
08:30 am
amix
Autonomix Selected to Present at the 2024 Octane Medical Innovation Forum
Low
Report
Autonomix Selected to Present at the 2024 Octane Medical Innovation Forum
9/9
07:00 am
amix
Autonomix Announces 83% Reduction of Pain at 4-6 Week Follow-Up from Lead-In Patients in Ongoing Human Clinical Trial in Pancreatic Cancer Pain Patients
Low
Report
Autonomix Announces 83% Reduction of Pain at 4-6 Week Follow-Up from Lead-In Patients in Ongoing Human Clinical Trial in Pancreatic Cancer Pain Patients
9/3
06:19 pm
amix
Autonomix Medical, Inc. (NASDAQ: AMIX) is now covered by analysts at LADENBURG THALM/SH SH. They set a "buy" rating and a $1.40 price target on the stock.
High
Report
Autonomix Medical, Inc. (NASDAQ: AMIX) is now covered by analysts at LADENBURG THALM/SH SH. They set a "buy" rating and a $1.40 price target on the stock.
8/27
08:30 am
amix
Autonomix Medical, Inc. to Present at H.C. Wainwright 26th Annual Global Investment Conference
Low
Report
Autonomix Medical, Inc. to Present at H.C. Wainwright 26th Annual Global Investment Conference